A systematic review of deep venous thrombosis prophylaxis in cancer patients: Implications for improving quality

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 929-936

  Leonardi, Michael J ^a   McGory, Marcia L ^a   Ko, Clifford Y ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Cancer; DVT; Heparin; Prophylaxis; Review; Surgery

Indexed keywords

DALTEPARIN; DERMATAN SULFATE; DEXTRAN 70; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ABDOMINAL CANCER; ABDOMINAL SURGERY; BLEEDING; CANCER PATIENT; CANCER SURGERY; CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOGRAPHY; ELECTIVE SURGERY; GASTROINTESTINAL SURGERY; GENERAL SURGERY; GYNECOLOGIC CANCER; HUMAN; INCIDENCE; LOW DRUG DOSE; MAJOR SURGERY; PELVIS SURGERY; PHLEBOGRAPHY; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; THORACIC CAVITY; THORAX SURGERY; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOSIS;

EID: 33846600853     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9183-9     Document Type: Review

References (33)

1. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. Circulation 1996; 93:2212-2245.
2. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:338S-400S.
3. Stratton MA, Anderson FA, Bussey HI, Caprini J, Comerota A, Haines ST, et al. Prevention of venous thromboembolism: Adherence to the 1995 American College of Chest Physicians Consensus Guidelines for Surgical Patients. Arch Intern Med 2000; 160:334-340.
4. Surgical Care Improvement Project - A National Quality Partnership, 11; http://www.medqic.org/scip.
5. Mismetti P, Laporte S, Darmon JY, Buchmuller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001; 88:913-930.
6. Nurmohamed MT, Verhaeghe R, Haas S, Iriarte JA, Vogel G, van Rij AM, et al. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995; 169:567-571.
7. Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallbook T, Hedberg M, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82:496-501.
8. Bergqvist D, Burmark US, Frisell J, Guilbaud O, Hallbook T, Horn A, et al. Thromboprophylactic effect of low molecular weight heparin started in the evening before elective general abdominal surgery: a comparison with low-dose heparin. Semin Thromb Hemost 1990; 16(Suppl):19-24.
9. Bergqvist D, Lindblad B, Ljungstrom KG, Persson NH, Hallbook T. Does dihydroergotamine potentiate the thromboprophylactic effect of dextran 70? A controlled prospective study in general and hip surgery. Br J Surg 1984; 71:516-521.
10. Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, et al. Prospective double-arm study of fibrinolysis in surgical patients. J Surg Res 1998; 74:96-101.
11. Allan A, Williams JT, Bolton JP, Le Quesne LP. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1983; 70:172-174.
12. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. ENOXACAN II Investigators. N Engl J Med 2002; 346:975-980.
13. Holford CP. Graded compression for preventing deep venous thrombosis. Br Med J 1976; 2:969-970.
14. Scurr JH, Ibrahim SZ, Faber RG, Le Quesne LP. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis. Br J Surg 1977; 64:371-373.
15. Torngren S. Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis. Br J Surg 1980; 67:482-484.
16. Butson AR. Intermittent pneumatic calf compression for prevention of deep venous thrombosis in general abdominal surgery. Am J Surg 1981; 142:525-527.
17. Covey TH, Sherman L, Baue AE. Low-dose heparin in postoperative patients: a prospective, coded study. Arch Surg 1975; 110:1021-1026.
18. Fricker JP, Vergnes Y, Schach R, Heitz A, Eber M, Grunebaum L, et al. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 1988; 18:561-567.
19. Gallus AS, Hirsh J, OBrien SE, McBride JA, Tuttle RJ, Gent M. Prevention of venous thrombosis with small, subcutaneous doses of heparin. JAMA 1976; 235:1980-1982.
20. Marassi A, Balzano G, Mari G, DAngelo SV, Della Valle P, Di Carlo V, et al. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216). Int Surg 1993; 78:166-170.
21. McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM, et al. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: Results of the canadian colorectal DVT prophylaxis trial: A randomized, double-blind trial. Canadian Colorectal Surgery DVT Prophylaxis Trial investigators. Ann Surg 2001; 233:438-44422.
22. Valle I, Sola G, Origone A. Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent post-operative deep venous thrombosis. Curr Med Res Opin 1988; 11:80-86.
23. Cade JF, Wood M, Magnani HN, Westlake GW. Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis. Thromb Res 1987; 45:497-503.
24. Di Carlo V, Agnelli G, Prandoni P, Coccheri S, Gensini GF. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group. Thromb Haemost Gianese F; 82:30-34.
25. Anonymous Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br J Surg 1997; 84:1099-1103.
26. Anonymous Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group. Br J Surg 1988; 75:1058-1063.
27. Wiig JN, Solhaug JH, Bilberg T, Bjerkeset T, Edwin B, Gruner OP, et al. Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicentre trials 20 mg and 40 mg enoxaparin versus dextran. Eur J Surg 1995; 161:663-668.
28. Joffe S. Drug prevention of postoperative deep venous thombosis. A comparative study of calcium heparinate and sodium pentosan polysulfate. Arch Surg 1976; 111:37-40.
29. Torngren S, Forsberg K. Concentrated or dilute heparin prophylaxis of postoperative deep venous thrombosis. Acta Chir Scand 1978; 144:283-288.
30. Haas S, Flosbach CW. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemost 1993; 19(Suppl 1):164-173.
31. Baykal C, Al A, Demirtas E, Ayhan A. Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: A randomised prospective double-blind clinical study. Eur J Gynaecol Oncol 2001; 22:127-130.
32. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, et al. Regional anesthesia in the anticoagulated patient: defining the risks (The Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Regional Anesthes Pain Med 28:172-197.
33. Warkentin T, Greinacher A. Heparin-induced thrombocytopenia: Recognition, treatment, and prevention. Chest 2004; 126:311S-337S.